[Form 4] BRUKER CORP Insider Trading Activity

Rhea-AI Filing Summary

Bruker Corporation (BRKR): Director insider transaction reported. On 11/06/2025, a director exercised stock options for 10,000 shares of common stock at $24 per share (Code M) and sold 6,233 shares (Code S) at a weighted average price of $39. The sale occurred in multiple trades within a range of $39.0001 to $39.0101.

Following these transactions, the director beneficially owned 35,212 shares directly. A related stock option originally granted on January 5, 2016, vested over three years and carries an expiration date of 01/05/2026. After the reported transactions, 10,000 derivative securities (stock options) were listed as beneficially owned.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

ORNELL JOHN A

(Last) (First) (Middle)

BRUKER CORPORATION

40 MANNING ROAD

(Street)

BILLERICA MA 01821

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
BRUKER CORP [ BRKR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
11/06/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/06/2025		M		10,000	A	$24	41,445	D
Common Stock	11/06/2025		S		6,233	D	$39(1)	35,212	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)	$24	11/06/2025		M		10,000		(2)	01/05/2026	Common Stock	10,000	$0	10,000	D

Explanation of Responses:

1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.0001 to $39.0101, inclusive. The reporting person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

2. The stock option granted to the Reporting Person on January 5, 2016 (the "Original Grant Date") vested in equal installments on the first, second and third anniversaries of the Original Grant Date.

	/s/ Michael Simone, Attorney-in-Fact	11/10/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider activity was reported for BRKR?

A director exercised 10,000 stock options at $24 and sold 6,233 shares at a weighted average of $39 on 11/06/2025.

How many BRKR shares did the insider sell and at what price?

The director sold 6,233 shares at a weighted average price of $39, with trades ranging from $39.0001 to $39.0101.

How many BRKR shares does the insider own after the transactions?

The director beneficially owns 35,212 shares directly following the reported transactions.

What were the terms of the exercised BRKR options?

The exercised option covered 10,000 shares at an exercise price of $24, originally granted on January 5, 2016, and it expires 01/05/2026.

What is the reporting person’s relationship to BRKR?

The reporting person is a Director of Bruker Corporation.

How many derivative securities remain beneficially owned?

Following the transactions, 10,000 derivative securities (stock options) were reported as beneficially owned.